{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T10:27:03Z","timestamp":1792578423094,"version":"4.5.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,2,21]],"date-time":"2012-02-21T00:00:00Z","timestamp":1329782400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1038\/nrneph.2012.19","type":"journal-article","created":{"date-parts":[[2012,2,21]],"date-time":"2012-02-21T10:30:24Z","timestamp":1329820224000},"page":"293-300","source":"Crossref","is-referenced-by-count":610,"title":["Glomerular hyperfiltration: definitions, mechanisms and clinical implications"],"prefix":"10.1038","volume":"8","author":[{"given":"Imed","family":"Helal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godela M.","family":"Fick-Brosnahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berenice","family":"Reed-Gitomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Schrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,21]]},"reference":[{"key":"BFnrneph201219_CR1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.0954-6820.1985.tb01655.x","volume":"217","author":"J Bergstr\u00f6m","year":"1985","unstructured":"Bergstr\u00f6m, J., Ahlberg, M. & Alvestrand, A. Influence of protein intake on renal hemodynamics and plasma hormone concentrations in normal subjects. Acta Med. Scand. 217, 189\u2013196 (1985).","journal-title":"Acta Med. Scand."},{"key":"BFnrneph201219_CR2","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1111\/j.1742-1241.2006.01037.x","volume":"60","author":"IM Pecly","year":"2006","unstructured":"Pecly, I. M., Genelhu, V. & Francischetti, E. A. Renal functional reserve in obesity hypertension. Int. J. Clin. Pract. 60, 1198\u20131203 (2006).","journal-title":"Int. J. Clin. Pract."},{"key":"BFnrneph201219_CR3","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/0002-9343(84)90529-1","volume":"77","author":"JP Bosch","year":"1984","unstructured":"Bosch, J. P., Lauer, A. & Glabman, S. Short-term protein loading in assessment of patients with renal disease. Am. J. Med. 77, 873\u2013879 (1984).","journal-title":"Am. J. Med."},{"key":"BFnrneph201219_CR4","first-page":"7","volume":"242","author":"BM Brenner","year":"1981","unstructured":"Brenner, B. M., Hostetter, T. H., Olson, J. L., Rennke, H. G. & Venkatachalam, M. A. The role of glomerular hyperfiltration in the initiation and progression of diabetic nephropathy. Acta Endocrinol. Suppl. (Copenh.) 242, 7\u201310 (1981).","journal-title":"Acta Endocrinol. Suppl. (Copenh.)"},{"key":"BFnrneph201219_CR5","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1038\/ki.1996.265","volume":"49","author":"BM Brenner","year":"1996","unstructured":"Brenner, B. M., Lawler, E. V. & Mackenzie, H. S. The hyperfiltration theory: a paradigm shift in nephrology. Kidney Int. 49, 1774\u20131777 (1996).","journal-title":"Kidney Int."},{"key":"BFnrneph201219_CR6","first-page":"F85","volume":"241","author":"TH Hostetter","year":"1981","unstructured":"Hostetter, T. H., Olson, J. L., Rennke, H. G., Venkatachalam, M. A. & Brenner, B. M. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am. J. Physiol. 241, F85\u2013F93 (1981).","journal-title":"Am. J. Physiol."},{"key":"BFnrneph201219_CR7","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/ki.1981.33","volume":"19","author":"TH Hostetter","year":"1981","unstructured":"Hostetter, T. H., Troy, J. L. & Brenner, B. M. Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int. 19, 410\u2013415 (1981).","journal-title":"Kidney Int."},{"key":"BFnrneph201219_CR8","first-page":"F324","volume":"249","author":"BM Brenner","year":"1985","unstructured":"Brenner, B. M. Nephron adaptation to renal injury or ablation. Am. J. Physiol. 249, F324\u2013F337 (1985).","journal-title":"Am. J. Physiol."},{"key":"BFnrneph201219_CR9","doi-asserted-by":"publisher","first-page":"S236","DOI":"10.1097\/00004872-198602000-00016","volume":"4","author":"S Anderson","year":"1986","unstructured":"Anderson, S. & Brenner, B. M. The role of intraglomerular pressure in the initiation and progression of renal disease. J. Hypertens. Suppl. 4, S236\u2013S238 (1986).","journal-title":"J. Hypertens. Suppl."},{"key":"BFnrneph201219_CR10","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1097\/00004872-199212000-00011","volume":"10","author":"JR Neuringer","year":"1992","unstructured":"Neuringer, J. R. & Brenner, B. M. Glomerular hypertension: cause and consequence of renal injury. J. Hypertens. Suppl. 10, S91\u2013S97 (1992).","journal-title":"J. Hypertens. Suppl."},{"key":"BFnrneph201219_CR11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/S0272-6386(12)70174-9","volume":"22","author":"JR Neuringer","year":"1993","unstructured":"Neuringer, J. R. & Brenner, B. M. Hemodynamic theory of progressive renal disease: a 10-year update in brief review. Am. J. Kidney Dis. 22, 98\u2013104 (1993).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201219_CR12","doi-asserted-by":"crossref","unstructured":"National Kidney Foundation. K\/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Part 4. Definition and classification of stages of chronic kidney disease. Am. J. Kidney Dis. 39, S46\u2013S75 (2002).","DOI":"10.1053\/ajkd.2002.30943"},{"key":"BFnrneph201219_CR13","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1093\/ndt\/16.7.1382","volume":"16","author":"G Dahlquist","year":"2001","unstructured":"Dahlquist, G., Stattin, E. L. & Rudberg, S. Urinary albumin excretion rate and glomerular filtration rate in the prediction of diabetic nephropathy; a long-term follow-up study of childhood onset type-1 diabetic patients. Nephrol. Dial. Transplant. 16, 1382\u20131386 (2001).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201219_CR14","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1111\/j.1523-1755.2005.00590.x","volume":"68","author":"R Amin","year":"2005","unstructured":"Amin, R. et al. The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: The Oxford Regional Prospective Study. Kidney Int. 68, 1740\u20131749 (2005).","journal-title":"Kidney Int."},{"key":"BFnrneph201219_CR15","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.2337\/diacare.21.12.2129","volume":"21","author":"RL Chaiken","year":"1998","unstructured":"Chaiken, R. L. et al. Hyperfiltration in African-American patients with type 2 diabetes. Cross-sectional and longitudinal data. Diabetes Care 21, 2129\u20132134 (1998).","journal-title":"Diabetes Care"},{"key":"BFnrneph201219_CR16","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/pbc.22971","volume":"56","author":"L Hjorth","year":"2011","unstructured":"Hjorth, L., Wiebe, T. & Karpman, D. Hyperfiltration evaluated by glomerular filtration rate at diagnosis in children with cancer. Pediatr. Blood Cancer 56, 762\u2013766 (2011).","journal-title":"Pediatr. Blood Cancer"},{"key":"BFnrneph201219_CR17","doi-asserted-by":"publisher","first-page":"274","DOI":"10.2215\/CJN.02760310","volume":"6","author":"SH Huang","year":"2011","unstructured":"Huang, S. H. et al. Hyperfiltration affects accuracy of creatinine eGFR measurement. Clin. J. Am. Soc. Nephrol. 6, 274\u2013280 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201219_CR18","first-page":"2473","volume":"354","author":"LA Stevens","year":"2006","unstructured":"Stevens, L. A., Coresh, J., Greene, T. & Levey, A. S. Assessing kidney function\u2014measured and estimated glomerular filtration rate. N. Engl. J. Med. 354, 2473\u20132483 (2006).","journal-title":"J. Med."},{"key":"BFnrneph201219_CR19","first-page":"539","volume-title":"Renal and Electrolyte Disorders","author":"M Cadnapaphornchai","year":"2003","unstructured":"Cadnapaphornchai, M., Briner, V. & Schrier, R. W. in Renal and Electrolyte Disorders (ed. Schrier, R. W.) 539\u2013579 (Lippincott Williams & Wilkins, Philadelphia, 2003)."},{"key":"BFnrneph201219_CR20","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/j.1365-2826.2010.01948.x","volume":"22","author":"RW Schrier","year":"2010","unstructured":"Schrier, R. W. & Ohara, M. Dilemmas in human and rat pregnancy: proposed mechanisms relating to arterial vasodilation. J. Neuroendocrinol. 22, 400\u2013406 (2010).","journal-title":"J. Neuroendocrinol."},{"key":"BFnrneph201219_CR21","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1681\/ASN.2009060653","volume":"21","author":"RW Schrier","year":"2010","unstructured":"Schrier, R. W. Systemic arterial vasodilation, vasopressin, and vasopressinase in pregnancy. J. Am. Soc. Nephrol. 21, 570\u2013572 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201219_CR22","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1046\/j.1523-1755.1998.00217.x","volume":"54","author":"AB Chapman","year":"1998","unstructured":"Chapman, A. B. et al. Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int. 54, 2056\u20132063 (1998).","journal-title":"Kidney Int."},{"key":"BFnrneph201219_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1196\/annals.1282.022","volume":"1041","author":"KP Conrad","year":"2005","unstructured":"Conrad, K. P., Jeyabalan, A., Danielson, L. A., Kerchner, L. J. & Novak, J. Role of relaxin in maternal renal vasodilation of pregnancy. Ann. NY Acad. Sci. 1041, 147\u2013154 (2005).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnrneph201219_CR24","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jsgi.2004.05.002","volume":"11","author":"KP Conrad","year":"2004","unstructured":"Conrad, K. P. Mechanisms of renal vasodilation and hyperfiltration during pregnancy. J. Soc. Gynecol. Investig. 11, 438\u2013448 (2004).","journal-title":"J. Soc. Gynecol. Investig."},{"key":"BFnrneph201219_CR25","doi-asserted-by":"publisher","first-page":"F592","DOI":"10.1152\/ajprenal.2001.280.4.F592","volume":"280","author":"MA Cadnapaphornchai","year":"2001","unstructured":"Cadnapaphornchai, M. A. et al. Chronic NOS inhibition reverses systemic vasodilation and glomerular hyperfiltration in pregnancy. Am. J. Physiol. Renal Physiol. 280, F592\u2013F598 (2001).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph201219_CR26","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s11255-009-9586-1","volume":"41","author":"II Gumus","year":"2009","unstructured":"Gumus, I. I. et al. Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Int. Urol. Nephrol. 41, 927\u2013932 (2009).","journal-title":"Int. Urol. Nephrol."},{"key":"BFnrneph201219_CR27","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/ki.1991.277","volume":"40","author":"N Bank","year":"1991","unstructured":"Bank, N. Mechanisms of diabetic hyperfiltration. Kidney Int. 40, 792\u2013807 (1991).","journal-title":"Kidney Int."},{"key":"BFnrneph201219_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1042\/CS20070088","volume":"114","author":"DZ Levine","year":"2008","unstructured":"Levine, D. Z. Can rodent models of diabetic kidney disease clarify the significance of early hyperfiltration?: recognizing clinical and experimental uncertainties. Clin. Sci. (Lond.) 114, 109\u2013118 (2008).","journal-title":"Clin. Sci. (Lond.)"},{"key":"BFnrneph201219_CR29","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/ki.1992.127","volume":"41","author":"JP Vora","year":"1992","unstructured":"Vora, J. P. et al. Renal hemodynamics in newly presenting non-insulin dependent diabetes mellitus. Kidney Int. 41, 829\u2013835 (1992).","journal-title":"Kidney Int."},{"key":"BFnrneph201219_CR30","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1056\/NEJM199611283352203","volume":"335","author":"RG Nelson","year":"1996","unstructured":"Nelson, R. G. et al. Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group. N. Engl. J. Med. 335, 1636\u20131642 (1996).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201219_CR31","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1681\/ASN.V7122627","volume":"7","author":"CK Keller","year":"1996","unstructured":"Keller, C. K., Bergis, K. H., Fliser, D. & Ritz, E. Renal findings in patients with short-term type 2 diabetes. J. Am. Soc. Nephrol. 7, 2627\u20132635 (1996).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201219_CR32","first-page":"93","volume":"17","author":"GT O'Bryan","year":"1997","unstructured":"O'Bryan, G. T. & Hostetter, T. H. The renal hemodynamic basis of diabetic nephropathy. Semin. Nephrol. 17, 93\u2013100 (1997).","journal-title":"Semin. Nephrol."},{"key":"BFnrneph201219_CR33","doi-asserted-by":"publisher","first-page":"5963","DOI":"10.1073\/pnas.82.17.5963","volume":"82","author":"R Zatz","year":"1985","unstructured":"Zatz, R., Meyer, T. W., Rennke, H. G. & Brenner, B. M. Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc. Natl Acad. Sci. USA 82, 5963\u20135967 (1985).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201219_CR34","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/ki.1993.57","volume":"43","author":"R Hirschberg","year":"1993","unstructured":"Hirschberg, R., Brunori, G., Kopple, J. D. & Guler, H. P. Effects of insulin-like growth factor I on renal function in normal men. Kidney Int. 43, 387\u2013397 (1993).","journal-title":"Kidney Int."},{"key":"BFnrneph201219_CR35","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/1056-8727(95)80028-D","volume":"9","author":"S Anderson","year":"1995","unstructured":"Anderson, S. & Vora, J. P. Current concepts of renal hemodynamics in diabetes. J. Diabetes Complications 9, 304\u2013307 (1995).","journal-title":"J. Diabetes Complications"},{"key":"BFnrneph201219_CR36","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/ki.1992.363","volume":"42","author":"M Sabbatini","year":"1992","unstructured":"Sabbatini, M. et al. Early glycosylation products induce glomerular hyperfiltration in normal rats. Kidney Int. 42, 875\u2013881 (1992).","journal-title":"Kidney Int."},{"key":"BFnrneph201219_CR37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1681\/ASN.V11171","volume":"11","author":"R Veelken","year":"2000","unstructured":"Veelken, R. et al. Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy. J. Am. Soc. Nephrol. 11, 71\u201379 (2000).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201219_CR38","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1111\/j.1476-5381.2010.01149.x","volume":"162","author":"Y Kuno","year":"2011","unstructured":"Kuno, Y., Iyoda, M., Shibata, T., Hirai, Y. & Akizawa, T. Sildenafil, a phosphodiesterase type 5 inhibitor, attenuates diabetic nephropathy in non-insulin-dependent Otsuka Long-Evans Tokushima Fatty rats. Br. J. Pharmacol. 162, 1389\u20131400 (2011).","journal-title":"Br. J. Pharmacol."},{"key":"BFnrneph201219_CR39","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00125-009-1268-0","volume":"52","author":"GM Magee","year":"2009","unstructured":"Magee, G. M. et al. Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis. Diabetologia 52, 691\u2013697 (2009).","journal-title":"Diabetologia"},{"key":"BFnrneph201219_CR40","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1681\/ASN.V10122569","volume":"10","author":"V Vallon","year":"1999","unstructured":"Vallon, V., Richter, K., Blantz, R. C., Thomson, S. & Osswald, H. Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption. J. Am. Soc. Nephrol. 10, 2569\u20132576 (1999).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201219_CR41","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1172\/JCI10963","volume":"107","author":"SC Thomson","year":"2001","unstructured":"Thomson, S. C. et al. Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes. J. Clin. Invest. 107, 217\u2013224 (2001).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201219_CR42","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/j.1365-2362.2005.01497.x","volume":"35","author":"G Vervoort","year":"2005","unstructured":"Vervoort, G., Veldman, B., Berden, J. H., Smits, P. & Wetzels, J. F. Glomerular hyperfiltration in type 1 diabetes mellitus results from primary changes in proximal tubular sodium handling without changes in volume expansion. Eur. J. Clin. Invest. 35, 330\u2013336 (2005).","journal-title":"Eur. J. Clin. Invest."},{"key":"BFnrneph201219_CR43","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1093\/ndt\/gfq008","volume":"25","author":"M Pruijm","year":"2010","unstructured":"Pruijm, M. et al. Glomerular hyperfiltration and increased proximal sodium reabsorption in subjects with type 2 diabetes or impaired fasting glucose in a population of the African region. Nephrol. Dial. Transplant. 25, 2225\u20132231 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201219_CR44","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1748-1716.2007.01705.x","volume":"190","author":"J S\u00e4llstr\u00f6m","year":"2007","unstructured":"S\u00e4llstr\u00f6m, J. et al. Diabetes-induced hyperfiltration in adenosine A1-receptor deficient mice lacking the tubuloglomerular feedback mechanism. Acta Physiol. (Oxf.) 190, 253\u2013259 (2007).","journal-title":"Acta Physiol. (Oxf.)"},{"key":"BFnrneph201219_CR45","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/ejcn.2010.22","volume":"64","author":"A Venezia","year":"2010","unstructured":"Venezia, A. et al. Dietary sodium intake in a sample of adult male population in southern Italy: results of the Olivetti Heart Study. Eur. J. Clin. Nutr. 64, 518\u2013524 (2010).","journal-title":"Eur. J. Clin. Nutr."},{"key":"BFnrneph201219_CR46","doi-asserted-by":"publisher","first-page":"3946","DOI":"10.1093\/ndt\/gfn379","volume":"23","author":"A Chagnac","year":"2008","unstructured":"Chagnac, A. et al. Obesity-induced glomerular hyperfiltration: its involvement in the pathogenesis of tubular sodium reabsorption. Nephrol. Dial. Transplant. 23, 3946\u20133952 (2008).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201219_CR47","doi-asserted-by":"publisher","first-page":"889","DOI":"10.2337\/dc08-1560","volume":"32","author":"LH Ficociello","year":"2009","unstructured":"Ficociello, L. H. et al. Renal hyperfiltration and the development of microalbuminuria in type 1 diabetes. Diabetes Care 32, 889\u2013893 (2009).","journal-title":"Diabetes Care"},{"key":"BFnrneph201219_CR48","first-page":"502","volume-title":"Diseases of the Kidney and Urinary Tract","author":"T Ecder","year":"2007","unstructured":"Ecder, T., Fick-Brosnahan, G. M. & Schrier, R. W. in Diseases of the Kidney and Urinary Tract 8th edn (ed. Schrier, R. W.) 502\u2013539 (Lippincott Williams & Wilkins, Philadelphia, 2007)."},{"key":"BFnrneph201219_CR49","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/ki.1983.51","volume":"23","author":"KA Franz","year":"1983","unstructured":"Franz, K. A. & Reubi, F. C. Rate of functional deterioration in polycystic kidney disease. Kidney Int. 23, 526\u2013529 (1983).","journal-title":"Kidney Int."},{"key":"BFnrneph201219_CR50","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1053\/ajkd.2002.33379","volume":"39","author":"GM Fick-Brosnahan","year":"2002","unstructured":"Fick-Brosnahan, G. M., Belz, M. M., McFann, K. K., Johnson, A. M. & Schrier, R. W. Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: a longitudinal study. Am. J. Kidney Dis. 39, 1127\u20131134 (2002).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201219_CR51","doi-asserted-by":"publisher","first-page":"148","DOI":"10.2215\/CJN.00330705","volume":"1","author":"JJ Grantham","year":"2006","unstructured":"Grantham, J. J., Chapman, A. B. & Torres, V. E. Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes. Clin. J. Am. Soc. Nephrol. 1, 148\u2013157 (2006).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201219_CR52","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.2215\/CJN.00360110","volume":"5","author":"E Meijer","year":"2010","unstructured":"Meijer, E. et al. Early renal abnormalities in autosomal dominant polycystic kidney disease. Clin. J. Am. Soc. Nephrol. 5, 1091\u20131098 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201219_CR53","doi-asserted-by":"publisher","first-page":"112","DOI":"10.2215\/CJN.00910306","volume":"2","author":"VE Torres","year":"2007","unstructured":"Torres, V. E. et al. Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease. Clin. J. Am. Soc. Nephrol. 2, 112\u2013120 (2007).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201219_CR54","first-page":"59","volume":"35","author":"D Dimitrakov","year":"1993","unstructured":"Dimitrakov, D., Kumchev, E., Lyutakova, E. & Grigorov, L. Glomerular hyperfiltration and serum beta 2-microglobulin used as early markers in diagnosis of autosomal dominant polycystic kidney disease. Folia Med. (Plovdiv) 35, 59\u201362 (1993).","journal-title":"Folia Med. (Plovdiv)"},{"key":"BFnrneph201219_CR55","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1053\/j.ajkd.2003.12.026","volume":"43","author":"H Wong","year":"2004","unstructured":"Wong, H., Vivian, L., Weiler, G. & Filler, G. Patients with autosomal dominant polycystic kidney disease hyperfiltrate early in their disease. Am. J. Kidney Dis. 43, 624\u2013628 (2004).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201219_CR56","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.2215\/CJN.01010211","volume":"6","author":"I Helal","year":"2011","unstructured":"Helal, I. et al. Glomerular hyperfiltration and renal progression in children with autosomal dominant polycystic kidney disease. Clin. J. Am. Soc. Nephrol. 6, 2439\u20132443 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"Suppl. 3","key":"BFnrneph201219_CR57","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.1097\/01.ASN.0000032549.36050.78","volume":"13","author":"M Volpe","year":"2002","unstructured":"Volpe, M. et al. The renin-angiotensin system as a risk factor and therapeutic target for cardiovascular and renal disease. J. Am. Soc. Nephrol. 13 (Suppl. 3), S173\u2013S178 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201219_CR58","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1056\/NEJM199010183231602","volume":"323","author":"AB Chapman","year":"1990","unstructured":"Chapman, A. B., Johnson, A., Gabow, P. A. & Schrier, R. W. The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. N. Engl. J. Med. 323, 1091\u20131096 (1990).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201219_CR59","doi-asserted-by":"publisher","first-page":"F775","DOI":"10.1152\/ajprenal.00370.2003","volume":"287","author":"M Loghman-Adham","year":"2004","unstructured":"Loghman-Adham, M., Soto, C. E., Inagami, T. & Cassis, S. The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease. Am. J. Physiol. Renal Physiol. 287, F775\u2013F788 (2004).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph201219_CR60","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1681\/ASN.2008080882","volume":"20","author":"RW Schrier","year":"2009","unstructured":"Schrier, R. W. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 20, 1888\u20131893 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201219_CR61","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.2215\/CJN.05260610","volume":"6","author":"S Santin","year":"2011","unstructured":"Santin, S. et al. Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome. Clin. J. Am. Soc. Nephrol. 6, 1139\u20131148 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201219_CR62","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1056\/NEJMe1106093","volume":"365","author":"JR Ingelfinger","year":"2011","unstructured":"Ingelfinger, J. R. MYO1E, focal segmental glomerulosclerosis, and the cytoskeleton. N. Engl. J. Med. 365, 368\u2013369 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201219_CR63","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S0272-6386(89)80001-0","volume":"13","author":"HG Rennke","year":"1989","unstructured":"Rennke, H. G. & Klein, P. S. Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis. Am. J. Kidney Dis. 13, 443\u2013456 (1989).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201219_CR64","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S0272-6386(99)70257-X","volume":"33","author":"M Praga","year":"1999","unstructured":"Praga, M. et al. Absence of hypoalbuminemia despite massive proteinuria in focal segmental glomerulosclerosis secondary to hyperfiltration. Am. J. Kidney Dis. 33, 52\u201358 (1999).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201219_CR65","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3109\/01913123.2011.584657","volume":"35","author":"S Darouich","year":"2011","unstructured":"Darouich, S. et al. Clinicopathological characteristics of obesity-associated focal segmental glomerulosclerosis. Ultrastruct. Pathol. 35, 176\u2013182 (2011).","journal-title":"Ultrastruct. Pathol."},{"key":"BFnrneph201219_CR66","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1046\/j.1523-1755.2001.0590041498.x","volume":"59","author":"N Kambham","year":"2001","unstructured":"Kambham, N., Markowitz, G. S., Valeri, A. M., Lin, J. & D'Agati, V. D. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 59, 1498\u20131509 (2001).","journal-title":"Kidney Int."},{"key":"BFnrneph201219_CR67","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1053\/j.ajkd.2006.07.025","volume":"48","author":"HM Chen","year":"2006","unstructured":"Chen, H. M. et al. Podocyte lesions in patients with obesity-related glomerulopathy. Am. J. Kidney Dis. 48, 772\u2013779 (2006).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201219_CR68","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1111\/j.1523-1755.2000.00384.x","volume":"58","author":"M Praga","year":"2000","unstructured":"Praga, M. et al. Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int. 58, 2111\u20132118 (2000).","journal-title":"Kidney Int."},{"key":"BFnrneph201219_CR69","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1523-1755.2005.00401.x","volume":"68","author":"E Gonz\u00e1lez","year":"2005","unstructured":"Gonz\u00e1lez, E. et al. Factors influencing the progression of renal damage in patients with unilateral renal agenesis and remnant kidney. Kidney Int. 68, 263\u2013270 (2005).","journal-title":"Kidney Int."},{"key":"BFnrneph201219_CR70","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1365-2141.2010.08477.x","volume":"153","author":"CT Quinn","year":"2011","unstructured":"Quinn, C. T. et al. for the Thalassemia Clinical Research Network. Renal dysfunction in patients with thalassaemia. Br. J. Haematol. 153, 111\u2013117 (2011).","journal-title":"Br. J. Haematol."},{"key":"BFnrneph201219_CR71","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1053\/ajkd.1998.v32.pm9708603","volume":"32","author":"F Schmitt","year":"1998","unstructured":"Schmitt, F. et al. Early glomerular dysfunction in patients with sickle cell anemia. Am. J. Kidney Dis. 32, 208\u2013214 (1998).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201219_CR72","doi-asserted-by":"publisher","first-page":"756","DOI":"10.2215\/CJN.08511109","volume":"5","author":"JP Haymann","year":"2010","unstructured":"Haymann, J. P. et al. Glomerular hyperfiltration in adult sickle cell anemia: a frequent hemolysis associated feature. Clin. J. Am. Soc. Nephrol. 5, 756\u2013761 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201219_CR73","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1681\/ASN.2010121316","volume":"22","author":"AH Arestegui","year":"2011","unstructured":"Arestegui, A. H. et al. High altitude renal syndrome (HARS). J. Am. Soc. Nephrol. 22, 1963\u20131968 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201219_CR74","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1007\/s00467-006-0220-5","volume":"21","author":"J Inatomi","year":"2006","unstructured":"Inatomi, J., Matsuoka, K., Fujimaru, R., Nakagawa, A. & Iijima, K. Mechanisms of development and progression of cyanotic nephropathy. Pediatr. Nephrol. 21, 1440\u20131445 (2006).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph201219_CR75","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1681\/ASN.V1261211","volume":"12","author":"JR Henegar","year":"2001","unstructured":"Henegar, J. R., Bigler, S. A., Henegar, L. K., Tyagi, S. C. & Hall, J. E. Functional and structural changes in the kidney in the early stages of obesity. J. Am. Soc. Nephrol. 12, 1211\u20131217 (2001).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201219_CR76","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1161\/01.HYP.26.4.610","volume":"26","author":"J Ribstein","year":"1995","unstructured":"Ribstein, J., du Cailar, G. & Mimran, A. Combined renal effects of overweight and hypertension. Hypertension 26, 610\u2013615 (1995).","journal-title":"Hypertension"},{"key":"BFnrneph201219_CR77","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1053\/j.ajkd.2010.03.017","volume":"56","author":"G Wuerzner","year":"2010","unstructured":"Wuerzner, G. et al. Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population. Am. J. Kidney Dis. 56, 303\u2013312 (2010).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201219_CR78","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1053\/j.ajkd.2010.06.005","volume":"56","author":"AS Levey","year":"2010","unstructured":"Levey, A. S. & Kramer, H. Obesity, glomerular hyperfiltration, and the surface area correction. Am. J. Kidney Dis. 56, 255\u2013258 (2010).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201219_CR79","doi-asserted-by":"publisher","first-page":"3732","DOI":"10.1093\/ndt\/gfp329","volume":"24","author":"DS Goumenos","year":"2009","unstructured":"Goumenos, D. S. et al. Early histological changes in the kidney of people with morbid obesity. Nephrol. Dial. Transplant. 24, 3732\u20133738 (2009).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201219_CR80","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1523-1755.2004.00351.x","volume":"65","author":"RJ Bosma","year":"2004","unstructured":"Bosma, R. J., van der Heide, J. J., Oosterop, E. J., de Jong, P. E. & Navis, G. Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects. Kidney Int. 65, 259\u2013265 (2004).","journal-title":"Kidney Int."},{"key":"BFnrneph201219_CR81","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/sj.ki.5002160","volume":"71","author":"M Tomaszewski","year":"2007","unstructured":"Tomaszewski, M. et al. Glomerular hyperfiltration: a new marker of metabolic risk. Kidney Int. 71, 816\u2013821 (2007).","journal-title":"Kidney Int."},{"key":"BFnrneph201219_CR82","first-page":"637","volume":"22","author":"A Serpa Neto","year":"2009","unstructured":"Serpa Neto, A. et al. Effect of weight loss after Roux-en-Y gastric bypass, on renal function and blood pressure in morbidly obese patients. J. Nephrol. 22, 637\u2013646 (2009).","journal-title":"J. Nephrol."},{"key":"BFnrneph201219_CR83","doi-asserted-by":"publisher","first-page":"S213","DOI":"10.1681\/ASN.2006080917","volume":"17","author":"M Navarro-D\u00edaz","year":"2006","unstructured":"Navarro-D\u00edaz, M. et al. Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up. J. Am. Soc. Nephrol. 17, S213\u2013S217 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201219_CR84","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1042\/CS20040074","volume":"107","author":"S Kinebuchi","year":"2004","unstructured":"Kinebuchi, S. et al. Short-term use of continuous positive airway pressure ameliorates glomerular hyperfiltration in patients with obstructive sleep apnea syndrome. Clin. Sci. (Lond.) 107, 317\u2013322 (2004).","journal-title":"Clin. Sci. (Lond.)"},{"key":"BFnrneph201219_CR85","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S0272-6386(87)80196-8","volume":"10","author":"JC Jennette","year":"1987","unstructured":"Jennette, J. C., Charles, L. & Grubb, W. Glomerulomegaly and focal segmental glomerulosclerosis associated with obesity and sleep-apnea syndrome. Am. J. Kidney Dis. 10, 470\u2013472 (1987).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201219_CR86","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1046\/j.1523-1755.2001.00952.x","volume":"60","author":"LF Casserly","year":"2001","unstructured":"Casserly, L. F. et al. Proteinuria in obstructive sleep apnea. Kidney Int. 60, 1484\u20131489 (2001).","journal-title":"Kidney Int."},{"key":"BFnrneph201219_CR87","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1046\/j.1523-1755.2000.00031.x","volume":"57","author":"MW Taal","year":"2000","unstructured":"Taal, M. W. & Brenner, B. M. Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists. Kidney Int. 57, 1803\u20131817 (2000).","journal-title":"Kidney Int."},{"key":"BFnrneph201219_CR88","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2337\/dc09-1303","volume":"33","author":"DZ Cherney","year":"2010","unstructured":"Cherney, D. Z. et al. Effect of direct renin inhibition on renal hemodynamic function, arterial stiffness, and endothelial function in humans with uncomplicated type 1 diabetes: a pilot study. Diabetes Care 33, 361\u2013365 (2010).","journal-title":"Diabetes Care"},{"key":"BFnrneph201219_CR89","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1755-1536-3-7","volume":"3","author":"IM van der Meer","year":"2010","unstructured":"van der Meer, I. M., Cravedi, P. & Remuzzi, G. The role of renin angiotensin system inhibition in kidney repair. Fibrogenesis Tissue Repair 3, 7 (2010).","journal-title":"Fibrogenesis Tissue Repair"},{"key":"BFnrneph201219_CR90","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","volume":"329","author":"EJ Lewis","year":"1993","unstructured":"Lewis, E. J., Hunsicker, L. G., Bain, R. P. & Rohde, R. D. for the Collaborative Study Group. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N. Engl. J. Med. 329, 1456\u20131462 (1993).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201219_CR91","doi-asserted-by":"publisher","first-page":"643","DOI":"10.7326\/0003-4819-118-8-199304150-00013","volume":"118","author":"GL Bakris","year":"1993","unstructured":"Bakris, G. L. Angiotensin-converting enzyme inhibitors and progression of diabetic nephropathy. Ann. Intern. Med. 118, 643\u2013644 (1993).","journal-title":"Ann. Intern. Med."},{"key":"BFnrneph201219_CR92","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1056\/NEJMoa011161","volume":"345","author":"BM Brenner","year":"2001","unstructured":"Brenner, B. M. et al. for the RENAAL Study Investigators. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N. Engl. J. Med. 345, 861\u2013869 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201219_CR93","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nrneph.2011.29","volume":"7","author":"N Nobakht","year":"2011","unstructured":"Nobakht, N., Kamgar, M., Rastogi, A. & Schrier, R. W. Limitations of angiotensin inhibition. Nat. Rev. Nephrol. 7, 356\u2013359 (2011).","journal-title":"Nat. Rev. Nephrol."},{"key":"BFnrneph201219_CR94","doi-asserted-by":"publisher","first-page":"R836","DOI":"10.1152\/ajpregu.00811.2007","volume":"294","author":"L Nordquist","year":"2008","unstructured":"Nordquist, L., Lai, E. Y., Sj\u00f6quist, M., Patzak, A. & Persson, A. E. Proinsulin C-peptide constricts glomerular afferent arterioles in diabetic mice. A potential renoprotective mechanism. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294, R836\u2013R841 (2008).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"BFnrneph201219_CR95","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.2337\/diabetes.54.7.2206","volume":"54","author":"F Pistrosch","year":"2005","unstructured":"Pistrosch, F. et al. Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients. Diabetes 54, 2206\u20132211 (2005).","journal-title":"Diabetes"},{"key":"BFnrneph201219_CR96","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/ndt\/gfg584","volume":"19","author":"G Luippold","year":"2004","unstructured":"Luippold, G., Beilharz, M. & M\u00fchlbauer, B. Chronic renal denervation prevents glomerular hyperfiltration in diabetic rats. Nephrol. Dial. Transplant. 19, 342\u2013347 (2004).","journal-title":"Dial. Transplant."},{"key":"BFnrneph201219_CR97","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1161\/01.HYP.0000105624.68174.00","volume":"43","author":"RB de Paula","year":"2004","unstructured":"de Paula, R. B., da Silva, A. A. & Hall, J. E. Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration. Hypertension 43, 41\u201347 (2004).","journal-title":"Hypertension"},{"key":"BFnrneph201219_CR98","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1681\/ASN.2009080820","volume":"21","author":"JH Ix","year":"2010","unstructured":"Ix, J. H. & Sharma, K. Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK. J. Am. Soc. Nephrol. 21, 406\u2013412 (2010).","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2012.19.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2012.19","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2012.19.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:38:38Z","timestamp":1684471118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2012.19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,21]]},"references-count":98,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["BFnrneph201219"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2012.19","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,21]]}}}